Search Results - "Calvani, Anna Maria"
-
1
Characterization of serious adverse drug reactions as cause of emergency department visit in children: a 5-years active pharmacovigilance study
Published in BMC pharmacology & toxicology (16-04-2018)“…To describe frequency, preventability and seriousness of adverse drug reactions (ADRs) in children as cause of emergency department (ED) admission and to…”
Get full text
Journal Article -
2
Repurposing drugs for the management of COVID-19
Published in Expert opinion on therapeutic patents (03-04-2021)“…: The coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 represents a serious health issue worldwide, with more than 61 million cases and more than 1.4…”
Get more information
Journal Article -
3
Epidemiological and Psychopharmacological Study About Off-Label Treatment in Child and Adolescent Psychiatric Emergencies: A Tertiary/Single Center Experience
Published in Pediatric emergency care (01-11-2022)“…The study used an epidemiological and pharmacological description of child and adolescent psychiatric emergencies (CAPEs), during which psychotropic…”
Get full text
Journal Article -
4
-
5
Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial
Published in Pediatric research (01-02-2017)“…Background: Oral propranolol reduces retinopathy of prematurity (ROP) progression, although not safely. This study evaluated safety and efficacy of propranolol…”
Get full text
Journal Article -
6
Pharmacokinetics and local safety profile of propranolol eye drops in rabbits
Published in Pediatric research (01-10-2014)“…Background: Oral propranolol, a nonselective β-blocker, is able to reduce the progression of retinopathy of prematurity in newborns, but it appeared unsafe…”
Get full text
Journal Article -
7
Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB Study
Published in Frontiers in pediatrics (07-05-2019)“…Oral propranolol reduces retinopathy of prematurity (ROP) progression, although not safely. Propranolol 0.1% eye micro-drops administered to newborns with…”
Get full text
Journal Article -
8
Stevens-johnson syndrome associated with drugs and vaccines in children: a case-control study
Published in PloS one (16-07-2013)“…Stevens-Johnson Syndrome (SJS) is one of the most severe muco-cutaneous diseases and its occurrence is often attributed to drug use. The aim of the present…”
Get full text
Journal Article -
9
Drug use and upper gastrointestinal complications in children: a case–control study
Published in Archives of disease in childhood (01-03-2013)“…Objective To evaluate the risk of upper gastrointestinal complications (UGIC) associated with drug use in the paediatric population. Methods This study is part…”
Get full text
Journal Article -
10
Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial
Published in BMC pediatrics (14-07-2017)“…Retinopathy of prematurity (ROP) still represents one of the leading causes of visual impairment in childhood. Systemic propranolol has proven to be effective…”
Get full text
Journal Article -
11
Effectiveness and safety of the A-H1N1 vaccine in children: a hospital-based case–control study
Published in BMJ open (01-01-2011)“…ObjectiveTo verify whether vaccination against the A-H1N1 virus in the paediatric population was effective in preventing the occurrence of influenza-like…”
Get full text
Journal Article